| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 9e-06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |